These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6178539)

  • 1. Exogenous mineralocorticoid-like disorders.
    Mantero F
    Clin Endocrinol Metab; 1981 Nov; 10(3):465-78. PubMed ID: 6178539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V; Parisio E; Ricci G
    Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exogenous mineralocorticoid hypertension: pathogenetic and clinical considerations].
    Armanini D
    G Clin Med; 1990; 71(8-9):483-92. PubMed ID: 2279623
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual cause of factitious mineralocorticoid excess.
    Vanderijst JF; Vandeleene B; De Plaen JF; Kolanowski J
    Acta Clin Belg; 1992; 47(6):408-13. PubMed ID: 1283935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray.
    Funder JW; Adam WR; Mantero F; Kraft N; Ulick S
    J Clin Endocrinol Metab; 1979 Dec; 49(6):842-6. PubMed ID: 92477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
    Virgolini L; Geatti O; Giunta G
    Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of gastrin, renin, aldosterone and electrolytes after administration of deglycyrrhizinized liquorice and carbenoxolone in healthy subjects].
    Baas EU; Holtermüller KH; Sinterhauf K; Walter U
    Z Gastroenterol; 1976 Apr; 14(2):273-6. PubMed ID: 802922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypokalemic myopathy in arterial hypertension].
    Santeusanio F; Nunzi E; Natali P; Nicoletti I; Angeletti G; Filipponi P; Rambotti P
    Minerva Med; 1982 Sep; 73(35):2279-86. PubMed ID: 7110606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokalemic myopathy associated with intranasal steroid use (factitious mineralocorticoid excess syndrome.
    Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D; Bisbocci D
    J Neurol; 1982; 226(4):265-8. PubMed ID: 6174707
    [No Abstract]   [Full Text] [Related]  

  • 10. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
    Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G
    Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent mineralocorticoid excess.
    Benediktsson R; Edwards CR
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases].
    Cuspidi C; Gelosa M; Moroni E; Sampieri L
    Minerva Med; 1981 Apr; 72(13):825-30. PubMed ID: 7012681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
    Armbruster H; Vetter W; Reck G; Beckerhoff R; Siegenthaler W
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):170-3. PubMed ID: 51837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypopotassemia and rhabdomyolysis. Description of 3 cases of different etiologies].
    Maresca MC; Calconi G; Amici GP; Teodori T; Da Porto A
    Minerva Med; 1988 Jan; 79(1):55-60. PubMed ID: 3340316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man.
    Epstein MT; Espiner EA; Donald RA; Hughes H
    Br Med J; 1977 Jan; 1(6055):209-10. PubMed ID: 832078
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineralocorticoid hypertension and hypokalemia.
    Khosla N; Hogan D
    Semin Nephrol; 2006 Nov; 26(6):434-40. PubMed ID: 17275580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P; Bongo IG; Borgna-Pignatti C; Severi F
    Helv Paediatr Acta; 1983 May; 38(2):185-9. PubMed ID: 6874387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineralocorticoid-like hypertension. "Apparent mineralocorticoid excess". A hereditary type of hypertension?].
    Christensen TH; Kaae HH; Ibsen H
    Ugeskr Laeger; 1999 Oct; 161(42):5800-3. PubMed ID: 10578695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licorice-induced hypermineralocorticoidism.
    Farese RV; Biglieri EG; Shackleton CH; Irony I; Gomez-Fontes R
    N Engl J Med; 1991 Oct; 325(17):1223-7. PubMed ID: 1922210
    [No Abstract]   [Full Text] [Related]  

  • 20. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
    Gordon RD
    Hypertension; 1986 Feb; 8(2):93-102. PubMed ID: 3002982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.